Adjuvant tamoxifen: how long before we know how long?

Suppr

超能文献

作者信息

Rea D, Poole C, Gray R

机构信息

Cancer Research Council Institute for Cancer Studies, University of Birmingham, Birmingham B15 2TA.

出版信息

BMJ. 1998 May 16;316(7143):1518-9. doi: 10.1136/bmj.316.7143.1518.

DOI:10.1136/bmj.316.7143.1518

PMID:9582148

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1113163/

Abstract

摘要

相似文献

Adjuvant tamoxifen: how long before we know how long?

BMJ. 1998 May 16;316(7143):1518-9. doi: 10.1136/bmj.316.7143.1518.

Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.

Lancet. 2003 Oct 4;362(9390):1156-7. doi: 10.1016/s0140-6736(03)14479-0.

Extended adjuvant therapy with letrozole: reducing the risk of recurrence.

Expert Rev Anticancer Ther. 2006 Jun;6(6):849-59. doi: 10.1586/14737140.6.6.849.

Tamoxifen versus toremifene in the adjuvant treatment of breast cancer.

Eur J Cancer. 2002 Nov;38 Suppl 6:S37-8. doi: 10.1016/s0959-8049(02)00279-4.

Long term adjuvant therapy for primary breast cancer.

BMJ. 1996 Feb 17;312(7028):389-90. doi: 10.1136/bmj.312.7028.389.

Re: Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999.

J Natl Cancer Inst. 2003 May 7;95(9):683; author reply 684-5. doi: 10.1093/jnci/95.9.683.

The optimal duration of adjuvant endocrine therapy for early stage breast cancer--with what drugs and for how long?

Curr Oncol Rep. 2014;16(1):358. doi: 10.1007/s11912-013-0358-9.

Breast cancer: new aspects of adjuvant hormonal therapy.

Ann Oncol. 2000;11 Suppl 3:13-25. doi: 10.1093/annonc/11.suppl_3.13.

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.

Lancet. 2011 Aug 27;378(9793):771-84. doi: 10.1016/S0140-6736(11)60993-8. Epub 2011 Jul 28.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

Lancet. 2005;365(9472):1687-717. doi: 10.1016/S0140-6736(05)66544-0.

引用本文的文献

Potential anti-genotoxic effect of sodium butyrate to modulate induction of DNA damage by tamoxifen citrate in rat bone marrow cells.

Cytotechnology. 2017 Feb;69(1):89-102. doi: 10.1007/s10616-016-0039-2. Epub 2016 Nov 30.

Gynaecological effects of tamoxifen.

J Clin Pathol. 1999 Feb;52(2):83-8. doi: 10.1136/jcp.52.2.83.

More large trials needed to decide best duration of treatment with tamoxifen.

BMJ. 1998 Nov 28;317(7171):1524. doi: 10.1136/bmj.317.7171.1524.

本文引用的文献

Postmastectomy radiotherapy in patients with breast cancer - Authors' reply.

Lancet. 2014 Nov 22;384(9957):1846-1847. doi: 10.1016/S0140-6736(14)62240-6. Epub 2014 Nov 21.

Preliminary results from the cancer research campaign trial evaluating tamoxifen duration in women aged fifty years or older with breast cancer. Current Trials working Party of the Cancer Research Campaign Breast Cancer Trials Group.

J Natl Cancer Inst. 1996 Dec 18;88(24):1834-9. doi: 10.1093/jnci/88.24.1834.

Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer. Eastern Cooperative Oncology Group.

J Natl Cancer Inst. 1996 Dec 18;88(24):1828-33. doi: 10.1093/jnci/88.24.1828.

Five years of tamoxifen--or more?

J Natl Cancer Inst. 1996 Dec 18;88(24):1791-3. doi: 10.1093/jnci/88.24.1791.

Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. Swedish Breast Cancer Cooperative Group.

J Natl Cancer Inst. 1996 Nov 6;88(21):1543-9. doi: 10.1093/jnci/88.21.1543.

Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors.

J Natl Cancer Inst. 1996 Nov 6;88(21):1529-42. doi: 10.1093/jnci/88.21.1529.

Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast cancer. The Scottish Cancer Trials Breast Group.

Br J Cancer. 1996 Jul;74(2):297-9. doi: 10.1038/bjc.1996.356.

Sudden fall in breast cancer death rates in England and Wales.

Lancet. 1995 Jun 24;345(8965):1642-3. doi: 10.1016/s0140-6736(95)90151-5.

Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two years.

Breast Cancer Res Treat. 1988 Dec;12(3):297-302. doi: 10.1007/BF01811242.

Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee.

BMJ. 1991 Aug 24;303(6800):435-7. doi: 10.1136/bmj.303.6800.435.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验